Smadl as a biomarker for diabetic nephropathy

Diabetes

Volumn 57, Issue 6, 2008, Pages 1459-1460

  Kato, Hideki ^a   Si, Han ^a   Hostetter, Thomas ^a   Susztak, Katalin ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; SMAD1 PROTEIN; SMAD1 PROTEIN, HUMAN;

ALBUMINURIA; CLINICAL RESEARCH; DIABETIC NEPHROPATHY; GENE EXPRESSION PROFILING; HUMAN; KIDNEY; METABOLOMICS; MICROARRAY ANALYSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEOMICS; RISK ASSESSMENT; MESANGIUM; PATHOLOGY; PATHOPHYSIOLOGY; URINE;

BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; GLOMERULAR MESANGIUM; HUMANS; SMAD1 PROTEIN;

EID: 48249089318     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0365     Document Type: Note

References (18)

1. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342:381-389, 2000
2. Colwell JA: Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes 45 (Suppl 3):S87-S90, 1996
3. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
4. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH: Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 67:1684-1691, 2005
5. Susztak K, Bottinger EP: Diabetic nephropathy: a frontier for personalized medicine. J Am Soc Nephrol 17:361-367, 2006
6. Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, Krolewski AS: Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 18:1353-1361, 2007
7. Lockhart DJ, Winzeler EA: Genomics, gene expression and DNA arrays. Nature 405:827-836, 2000
8. Iyengar SK, Schelling JR, Sedor JR: Approaches to understanding susceptibility to nephropathy: from genetics to genomics. Kidney Int 61:61-67, 2002
9. Gershon D: Microarray technology: an array of opportunities. Nature 416:885-891, 2002
10. Mueller PW, Rogus JJ, Cleary PA, Zhao Y, Smiles AM, Steffes MW, Bucksa J, Gibson TB, Cordovado SK, Krolewski AS, Nierras CR, Warram JH: Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 17:1782-1790, 2006
11. Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Elston RC, Hanson RL, Ipp E, Kao WH, Kimmel PL, Klag MJ, Knowler WC, Meoni LA, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Quade SR, Rich SS, Rotter JI, Scavini M, Schelling JR, Sedor JR, Sehgal AR, Shah VO, Smith MW, Taylor KD, Winkler CA, Zager PG, Freedman BI, Family Investigation of Nephropathy and Diabetes Research Group: Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes 56:1577-1585, 2007
12. Schelling JR, Abboud HE, Nicholas SB, Pahl MV, Sedor JR, Adler SG, Arar NH, Bowden DW, Elston RC, Freedman BI, Goddard KA, Guo X, Hanson RL, Ipp E, Iyengar SK, Jun G, Kao WH, Kasinath BS, Kimmel PL, Klag MJ, Knowler WC, Nelson RG, Parekh RS, Quade SR, Rich SS, Saad MF, Scavini M, Smith MW, Taylor K, Winkler CA, Zager PG, Shah VO, Family Investigation of Nephropathy and Diabetes Research Group: Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes 57:235-243, 2008
13. Kretzler M, Cohen CD, Doran P, Henger A, Madden S, Grone EF, Nelson PJ, Schlondorff D, Grone HJ: Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology. J Am Soc Nephrol 13:1961-1972, 2002
14. KB transcriptional programs in human diabetic nephropathy. Diabetes 55:2993-3003, 2006
15. Thongboonkerd V, Barati MT, McLeish KR, Pierce WM, Epstein PN, Klein JB: Proteomics and diabetic nephropathy. Contrib Nephrol 141:142-154, 2004
16. Sharma K, Lee S, Han S, Lee S, Francos B, McCue P, Wassell R, Shaw MA, RamachandraRao SP: Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 5:2648-2655, 2005
17. Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, Knueppel S, Haller H, Fliser D: Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond) 107:485-495, 2004
18. Mima AAH, Matshubara T, Abe H, Nagai K, Tamura Y, Torikoshi K, Araki M, Kanamori H, Takahashi T, Tominaga T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T: Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy. Diabetes 57:1712-1722, 2008